Here’s some good news that should brighten up this cold and snowy January: The FDA has just approved a new antidepressant with minimal sexual side effects.
The most commonly used class of antidepressants — called selective serotonin re-uptake inhibitors (SSRIs) — has quickly risen to the top of the charts for their ability to treat depression. These include such household names as Prozac, Paxil and Zoloft. But there’s one problem with SSRIs: Many of them cause sexual dysfunction, including problems with achieving erection, delayed orgasm and loss of libido. As a result, patients frequently abandon their medication.
The new drug, vilazodone, was developed by the company Clinical Data and will be marketed under the brand name Viibyrd. (Yes, that’s right.) In clinical trials, it did not have a negative impact on sexual desire or function.
Read the rest of this story at www.PoliticsDaily.com…
Prozac Sprinkles by Lushbunny via Flickr under a Creative Commons License